Scientists Suggest New Way to Help Measure Obesity Instead of Just Using Traditional BMI Metric
A new report noted that body mass index does not provide a nuanced enough assessment of health as it relates to weight
Hosted on MSN6d
Experts look to abandon BMI, find new ways to define obesity
The way the world defines obesity has been in need of an overhaul, according to some experts, and it could be coming soon thanks to a new set of standards.
Obesity won't be solely defined by BMI under new plan for diagnosis by global experts
New recommendations on how to define obesity would reduce the emphasis on body mass index and take into account health problems from extra weight and other measurements.
Americans might finally have to face what’s in their food
A front-of-package food label would be a great educational tool. The Trump administration should keep it.
A new definition of obesity goes beyond BMI. What this could mean for you
A commission proposed a new definition of obesity focused on how excess fat affects the body, rather than assessing body mass index, that could change clinical care.
Ozempic’s health benefits keep growing, but are the risks worth it?
A major new study has revealed a long list of benefits and some little-known risks of Ozempic and other GLP-1 medications. Experts break down the findings.
earth8d
Weight-loss drugs like Ozempic found to have other unexpected benefits
The study revealed that weight-loss drugs significantly benefit neurological and behavioral health, including decreased risks of addiction.
Massive study looks at benefits, risks of GLP-1 weight-loss drugs
As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has uncovered neurological and behavioral health benefits amid risks for pancreatitis and kidney disease.
seattlepi.com9d
Ozempic and similar weight loss drugs may lower risk of 42 health conditions, but also pose risks
Ziyad Al-Aly, Washington University in St. Louis (THE CONVERSATION ... have become household names and key tools in the fight against obesity: 1 in 8 American adults say they have used a GLP-1 drug, and forecasts show that by 2030, 1 in 10 Americans ...
FiercePharma9d
Large study of Novo, Lilly weight loss drugs shows decrease in risk of Alzheimer's
As evidence has mounted that new diabetes and weight loss drugs can provide a variety of health benefits, the FDA has approved Novo Nordisk’s semaglutide for heart disease and Eli Lilly’s tirzepati | An observational study from Washington University in St.
Dentistry9d
Weight loss jabs linked to reduced dementia – but could damage organs
Weight loss jabs, such as Wegovy, have been linked to reduced risk of dementia and seizures – but increased risk of other disorders.
The Health Risks and Benefits of Weight-Loss Drugs
T he newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ways they affect the body—both helpful and harmful—beyond reducing weight. In report published in Nature Medicine,